Jennifer M. MacRae

Jennifer M. MacRae

Auto-generated profile, based on publicly available information

Jennifer M. MacRae

Cumming School of Medicine, University of Calgary, Calgary, Canada

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2013 in Journal of the American Society of Nephrology
Verified
Journal Article
Open access
PDF file
PRPietro Ravani
Pietro Ravani
SPSuetonia C. Palmer
Suetonia C. Palmer
MOMatthew J. Oliver
Matthew J. Oliver
RQRobert R. Quinn
Robert R. Quinn
JMJennifer M. MacRae
Jennifer M. MacRae
MJMatthew T. James
Matthew T. James
Clinical practice guidelines recommend an arteriovenous fistula as the preferred vascular access for hemodialysis, but quantitative associations between vascular access type and various clinical outcomes remain controversial. We performed a systematic review of cohort studies to evaluate the associations between type of vascular access (arteriovenous fistula, arteriovenous graft, and central venous catheter) and risk for death, infection, and major cardiovascular events. We searched MEDLINE, EMBASE, and article reference lists and extracted data describing study design, participants, vascular access type, clinical outcomes, and risk for bias. We identified 3965 citations, of which 67 (62 cohort studies comprising 586,337 participants) met our inclusion criteria. In a random effects meta-analysis, compared with persons with fistulas, those individuals using catheters had higher risks for all-cause mortality (risk ratio=1.53, 95% CI=1.41–1.67), fatal infections (2.12, 1.79–2.52), and cardiovascular events (1.38, 1.24–1.54). Similarly, compared with persons with grafts, those individuals using catheters had higher risks for mortality (1.38, 1.25–1.52), fatal infections (1.49, 1.15–1.93), and cardiovascular events (1.26, 1.11–1.43). Compared with persons with fistulas, those individuals with grafts had increased all-cause mortality (1.18, 1.09–1.27) and fatal infection (1.36, 1.17–1.58), but we did not detect a difference in the risk for cardiovascular events (1.07, 0.95–1.21). The risk for bias, especially selection bias, was high. In conclusion, persons using catheters for hemodialysis seem to have the highest risks for death, infections, and cardiovascular events compared with other vascular access types, and patients with usable fistulas have the lowest risk.

19 October 2009 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
BHBrenda R Hemmelgarn
Brenda R Hemmelgarn
FCFiona Clement
Fiona Clement
BMBraden J Manns
Braden J Manns
SKScott Klarenbach
Scott Klarenbach
MJMatthew T James
Matthew T James
MTMarcello Tonelli
Marcello Tonelli
The Alberta Kidney Disease Network is a collaborative nephrology research organization based on a central repository of laboratory and administrative data from the Canadian province of Alberta.

1 January 2005 in ASAIO Journal
Verified
Journal Article
Closed access
JMJennifer M. MacRae
Jennifer M. MacRae
AAAyesha Ahmed
Ayesha Ahmed
NJNathan Johnson
Nathan Johnson
ALAdeera Levin
Adeera Levin
MKMercedeh Kiaii
Mercedeh Kiaii
Central vein stenosis (CVS) has been associated with subclavian (SCV) catheter insertions. The prevalence of CVS in the current era with minimal use of SCV catheters is unknown. Furthermore, the prevalence of CVS in patients with access problems has not been previously described to our knowledge. We evaluated 235 prevalent patients on hemodialysis (HD), and, of these, 133 underwent venography for access related concerns over a 14 month period. Of these 133 patients, 55 (41%) had evidence of significant CVS on venogram. Patients with CVS had a longer duration on HD (43 ± 12 months vs. 34 ± 15 months, p = 0.018) and a history of a previous HD catheter insertion (52/55 patients vs. 59/78 patients, p = 0.0039). There were only 18 patients with a subclavian catheter insertion. In those with any history of previous HD catheter insertion, multivariate analysis demonstrated that number of catheters remains a significant factor (OR 2.69, p = 0.0004) even after excluding those subclavian insertions. This study demonstrates that CVS occurs in almost half of the patients with access problems undergoing venography. We confirm the important contribution of central vein cannulation to CVS and show that, despite minimizing subclavian catheter insertion, CVS remains a relatively common occurrence. Thus further studies should attempt to determine the true incidence of this problem and ultimately address the optimal treatment strategies.

1 May 2004 in American Journal of Kidney Diseases
Verified
Journal Article
Closed access
PDF file
JMJennifer M MacRae
Jennifer M MacRae
SPSanjay Pandeya
Sanjay Pandeya
DHDennis P Humen
Dennis P Humen
NKNikolai Krivitski
Nikolai Krivitski
RLRobert M Lindsay
Robert M Lindsay

31 January 2011 in Nephrology Dialysis Transplantation
Verified
Journal Article
Open access
PDF file
DMDavid C. Mendelssohn
David C. Mendelssohn
BCBryan Curtis
Bryan Curtis
KYKaren Yeates
Karen Yeates
SLSerge Langlois
Serge Langlois
JMJennifer M. MacRae
Jennifer M. MacRae
FIfor the STARRT Study investigators
for the STARRT Study investigators
Background. Our objective was to examine patients who initiate renal replacement therapy (RRT) at 10 representative Canadian centers, characterize their initiation as inpatient or outpatient and describe their initial type of dialysis access, duration of pre-dialysis care and clinical status at the time of dialysis initiation. We also examined the impact of an optimal dialysis start (i.e. initiated as an outpatient with an arteriovenous fistula, arteriovenous graft or peritoneal dialysis catheter) on subsequent health outcomes. Methods. Charts of consecutive incident RRT patients were identified from 1 July to 31 December 2006. Information was collected until 6 months after the initiation or until death, transplant or transfer. Results. Three hundred and thirty-nine incident RRT patients were studied: 39.6% initiated as an inpatient; 54% started hemodialysis (HD) with a central venous catheter; 15.3% had 1 year. Optimal starts occurred in 39.5% of patients. For HD patients, optimal starts occurred in 19.8%. Suboptimal starts were noted in patients referred <12 months prior to end-stage renal disease (44%) and in patients referred earlier (56%). The composite end point of death, transfusion or subsequent hospitalization was significantly reduced with an optimal start [hazard ratio 0.47 (95% confidence interval 0.32–0.68), P = 0.0001]. Conclusions. Suboptimal initiation of dialysis is common in patients referred early or late. The benefits of early referral are lost if dialysis is initiated suboptimally. There is a need to identify factors that lead to suboptimal initiation despite early referral.

1 January 2016 in Canadian Journal of Kidney Health and Disease
Verified
Journal Article
Open access
JMJennifer M. MacRae
Jennifer M. MacRae
CDChristine Dipchand
Christine Dipchand
MOMatthew Oliver
Matthew Oliver
LMLouise Moist
Louise Moist
CLCharmaine Lok
Charmaine Lok
OGon behalf of the Canadian Society of Nephrology Vascular Access Work Group
on behalf of the Canadian Society of Nephrology Vascular Access Work Group
Vascular access–related complications can lead to patient morbidity and reduced patient quality of life. Some of the common arteriovenous access complications include failure to mature, stenosis formation, and thrombosis.